Remibrutinib Improves Chronic Spontaneous Urticaria in Patients Irrespective of Previous Anti-IgE Treatment: Results From a Phase 2b Study

被引：0
|
作者：
Greiner, Alexander [1 ,2 ]
Guduri, Sridhar [3 ]
Leflein, Jeffrey [4 ]
Haemmerle, Sibylle [5 ]
Lheritier, Karine [5 ]
Walsh, Pauline [6 ]
Nikolaev, Ivan [5 ]
Gimenez-Arnau, Ana [7 ]
Maurer, Marcus [8 ]
机构：
[1] Allergy & Asthma Med Grp & Res Ctr, San Diego, CA USA
[2] Univ Calif San Diego, San Diego, CA USA
[3] Centricity Res Inc, Columbus, OH USA
[4] Resp Med Res Inst Michigan, Ann Arbor, MI USA
[5] Novartis Pharma AG, Basel, Switzerland
[6] Novartis Ireland Ltd, Dublin, Ireland
[7] Univ Pompeu Fabra, Hosp Mar IMIM, Barcelona, Spain
[8] Charit Univ Med Berlin, Urticaria Ctr Reference & Excellence UCARE, Berlin, Germany
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2023年 / 151卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
404
引用
收藏
页码：AB131 / AB131
页数：1
相关论文
共 50 条
  • [41] Omalizumab improves angioedema-related quality of life impairment in chronic spontaneous urticaria patients: Results from the X-ACT study
    Weller, Karsten
    Staubach, Petra
    Metz, Martin
    Chapman-Rothe, Nadine
    Sieder, Christian
    Brautigam, Matthias
    Maurer, Marcus
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB209 - AB209
  • [42] Profile and treatment of patients suffering from chronic urticaria in France: Results of the ETNA study
    Amsler, Emmanuelle
    Thenie, Claire
    Le Corre, Yves
    Elfasci, Carole Ohayon
    Cordier, Jean Marc
    Guillet, Gerard
    Amans, Jean Marc
    Garcin, Patrick
    Dalampira, Georgia
    Benslimane, Samir
    Godesky, Franck
    Hacard, Florence
    Chauffaille, Bernadette
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB100 - AB100
  • [43] Chronic Spontaneous Urticaria in elderly Patients: Patient Characteristics, Comorbidities and Treatment Patterns, Results of the German AWARE Study
    Maurer, M.
    Raap, U.
    Staubach, P.
    Richter-Huhn, G.
    Chaouche, K.
    Chapman-Rothe, N.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2017, 15 : 72 - 73
  • [44] Clinical improvement after treatment with anti-IgE antibody is associated with reduced frequencies of IFN-gamma-, IL-10-and IL-31-secreting T cells in patients with chronic spontaneous urticaria
    Rauber, M. M.
    Pickert, J.
    Holiangu, L.
    Moebs, C.
    Pfuetzner, W.
    EXPERIMENTAL DERMATOLOGY, 2018, 27 (03) : E70 - E70
  • [45] Ligelizumab as add-on therapy for patients with H1-antihistamine-refractory chronic spontaneous urticaria: primary results of a placebo- and active-controlled phase 2b dose-finding study
    Maurer, M.
    Gimenez-Arnau, A.
    Sussman, G.
    Loeffler, J.
    Barve, A.
    Severin, T.
    Janocha, R.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 : 121 - 121
  • [46] Results of a phase 2B study of the humanized anti-C5 antibody eculizumab in patients with rheumatoid arthritis
    Mojcik, CF
    Kremer, J
    Bingham, C
    Burch, F
    Vitiello, S
    McCroskery, E
    Bookbinder, S
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 301 - 301
  • [47] Effect of Linaclotide On IBS-Symptoms in the First Week of Treatment: Results from a Phase 2B Study
    Lembo, Anthony J.
    Johnston, Jeffrey M.
    Lavins, Bernard J.
    MacDougall, James E.
    Schneier, Harvey
    Shiff, Steven J.
    Kurtz, Caroline B.
    Currie, Mark G.
    GASTROENTEROLOGY, 2009, 136 (05) : A30 - A31
  • [48] Setrusumab for the treatment of osteogenesis imperfecta: 12-month results from the phase 2b asteroid study
    Glorieux, Francis H.
    Langdahl, Bente
    Chapurlat, Roland
    De Beur, Suzanne Jan
    Sutton, Vernon Reid
    Poole, Kenneth E. S.
    Dahir, Kathryn M.
    Orwoll, Eric S.
    Willie, Bettina M.
    Mikolajewicz, Nicholas
    Zimmermann, Elizabeth
    Hosseinitabatabaei, Seyedmahdi
    Ominsky, Michael S.
    Saville, Chris
    Clancy, James
    Macinnon, Alastair
    Mistry, Arun
    Javaid, Muhammad K.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2024, 39 (09) : 1215 - 1228
  • [49] Study design and rationale of a phase 3b extension study of ligelizumab in adult and adolescent patients with chronic spontaneous urticaria
    Severin, T.
    Maurer, M.
    Gimenez-Arnau, A. M.
    Hide, M.
    Sussman, G.
    Saini, S. S.
    Hua, E.
    Barve, A.
    Joubert, Y.
    Indermuehle, I.
    Janocha, R.
    ALLERGY, 2020, 75 : 446 - 447
  • [50] Reduced Effectiveness of Anti-IgE Treatment Among Adults with Severe Asthma with Older Age of Asthma Onset: Results from the CHRONICLE Study
    Ledford, Dennis K.
    Carr, Warner W.
    Moore, Wendy C.
    Lugogo, Njira L.
    Mohan, Arjun
    Chipps, Bradley
    Mackie, Alexander R.
    Lindsley, Andrew W.
    Spahn, Joseph
    Ambrose, Christopher S.
    JOURNAL OF ASTHMA AND ALLERGY, 2024, 17 : 977 - 982
12345